A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge <i>In Vivo</i>
Junping Hong, L. Zhong, Qingbing Zheng, Qian Wu, Zhenghui Zha, Dongmei Wei, Haiwen Chen, Wanlin Zhang, Shanshan Zhang, Yang Huang, Kai‐Yun Chen, Junyu Chen, Shaowei Li, Mu‐Sheng Zeng, Yi‐Xin Zeng, Ningshao Xia, Xiao Zhang, Miao Xu, Yixin Chen
Abstract
Epstein-Barr virus (EBV) is a ubiquitous gammaherpesvirus that establishes lifelong persistence and is related to multiple diseases, including cancers. Neutralizing antibodies (NAbs) have proven to be highly effective in preventing EBV infection and subsequent diseases.
Topics & Concepts
VirologyBiologyEpitopeVirusNeutralizing antibodyEpstein–Barr virusAntibodyImmunologyIn vivoBiotechnologyViral-associated cancers and disordersLymphoma Diagnosis and TreatmentParvovirus B19 Infection Studies